Unknown

Dataset Information

0

Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound.


ABSTRACT: The blood-brain barrier (BBB) presents a significant obstacle for the treatment of many central nervous system (CNS) disorders, including invasive brain tumors, Alzheimer's, Parkinson's and stroke. Therapeutics must be capable of bypassing the BBB and also penetrate the brain parenchyma to achieve a desired effect within the brain. In this study, we test the unique combination of a non-invasive approach to BBB permeabilization with a therapeutically relevant polymeric nanoparticle platform capable of rapidly penetrating within the brain microenvironment. MR-guided focused ultrasound (FUS) with intravascular microbubbles (MBs) is able to locally and reversibly disrupt the BBB with submillimeter spatial accuracy. Densely poly(ethylene-co-glycol) (PEG) coated, brain-penetrating nanoparticles (BPNs) are long-circulating and diffuse 10-fold slower in normal rat brain tissue compared to diffusion in water. Following intravenous administration of model and biodegradable BPNs in normal healthy rats, we demonstrate safe, pressure-dependent delivery of 60nm BPNs to the brain parenchyma in regions where the BBB is disrupted by FUS and MBs. Delivery of BPNs with MR-guided FUS has the potential to improve efficacy of treatments for many CNS diseases, while reducing systemic side effects by providing sustained, well-dispersed drug delivery into select regions of the brain.

SUBMITTER: Nance E 

PROVIDER: S-EPMC4125545 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound.

Nance Elizabeth E   Timbie Kelsie K   Miller G Wilson GW   Song Ji J   Louttit Cameron C   Klibanov Alexander L AL   Shih Ting-Yu TY   Swaminathan Ganesh G   Tamargo Rafael J RJ   Woodworth Graeme F GF   Hanes Justin J   Price Richard J RJ  

Journal of controlled release : official journal of the Controlled Release Society 20140628


The blood-brain barrier (BBB) presents a significant obstacle for the treatment of many central nervous system (CNS) disorders, including invasive brain tumors, Alzheimer's, Parkinson's and stroke. Therapeutics must be capable of bypassing the BBB and also penetrate the brain parenchyma to achieve a desired effect within the brain. In this study, we test the unique combination of a non-invasive approach to BBB permeabilization with a therapeutically relevant polymeric nanoparticle platform capab  ...[more]

Similar Datasets

| S-EPMC5593770 | biostudies-literature
| S-EPMC1544236 | biostudies-literature
| S-EPMC3218061 | biostudies-literature
| S-EPMC7260193 | biostudies-literature
| S-EPMC8449371 | biostudies-literature
| S-EPMC4490035 | biostudies-literature
| S-EPMC4101537 | biostudies-literature
| S-EPMC5226140 | biostudies-other
| S-EPMC6060168 | biostudies-literature
| S-EPMC7924515 | biostudies-literature